IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Trident Texofab IPO listing price is ₹ 68.00, issue price is [●], and currently trading at ₹ 199.95 as on May 30, 2025. Trident Texofab IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Trident Texofab IPO is a Fixed Price listing on BSE SME exchange. The company is based in Surat and caters to Textiles sector. Guiness Corporate Advisors is the merchant banker of Trident Texofab IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Trident Texofab IPO offer price is ₹ 30.00 and got listed at ₹ 68.00. Read Trident Texofab IPO details mentioned above.The IPO of Trident Texofab Limited was listed on 5th October 2017. As of today, Trident Texofab IPO is trading at ₹ 199.95, compared to the previous day’s close of ₹ 204.00. Read the report above for detailed IPO performance.
The issue price of Trident Texofab IPO was [●] per equity share.
Trident Texofab IPO was listed at ₹68.00 on the stock exchange on 5th October 2017. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Trident Texofab IPO is ₹ 199.95.
The 52-week high for Trident Texofab IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Trident Texofab IPO listed at ₹ 68.00 against the issue price of [●] per equity share, showing a listing day gain/loss of 38 (126.67%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Trident Texofab IPO stock moved from its listing price of ₹ 68.00 to the current price of ₹199.95 per equity share, reflecting a change of 194.04% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Trident Texofab IPO issue date of May 30, 2025 and CMP of ₹199.95, the estimated CAGR is approximately 28.11%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
[●]
Listing Price :
₹ 68.00
Previous Day Closing
₹ 204.00
Trident Texofab IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Trident Texofab Financial Review Page
Merchant Banker(s) of Trident Texofab IPO: Guiness Corporate Advisors Private Limited
Trident Texofab IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Trident Texofab IPO listed at a listing price of 68.00 against the offer price of 30.00.
The current market price of Trident Texofab is 199.95.
Why Us?
